Results 221 to 230 of about 1,416,392 (341)

Impact Factor Evolution of Clinical Neuroradiology

Clinical Neuroradiology, 2023
openaire   +2 more sources

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

Molecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici, Soheil Akbari, Ceyda Caliskan, Canan Celiker, Ozden Oz, Leman Binokay, Gökhan Karakulah, Serif Senturk, Esra Erdal   +8 more
wiley   +1 more source

The clinical evolution of patients with idiopathic spinal cord herniation: a case series. [PDF]

Spinal Cord Ser Cases
Flageol S, Carrondo-Cottin S, Turmel A, Côté I, Paquet J.   +4 more
europepmc   +1 more source

Clinical Evolution of Preschool Picky Eater Children Receiving Oral Nutritional Supplementation during Six Months: A Prospective Controlled Clinical Trial. [PDF]

Children (Basel), 2023
Nogueira-de-Almeida CA, Del Ciampo LA, Martinez EZ, Contini AA, Nogueira-de-Almeida ME, Ferraz IS, Epifanio M, da Veiga Ued F.   +7 more
europepmc   +1 more source

T19. EVOLUTION OF ANTI-NMDA RECEPTOR ENCEPHALITIS CLINICAL FEATURES IN CHILDREN AND ADOLESCENTS [PDF]

, 2019
Ronald J. Gurrera
openalex   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

Clinical evolution of bladder carcinosarcoma: A case report and literature review. [PDF]

Medicine (Baltimore)
Wu S, Wang X, Zuo Y, Wang K, Ye M, Wang C.   +5 more
europepmc   +1 more source

Clinical evolution of antisynthetase syndrome after SARS-CoV2 infection: a 6-month follow-up analysis. [PDF]

Clin Rheumatol, 2022
Vertui V, Zanframundo G, Castañeda S, Biglia A, Palermo BL, Cavazzana I, Meloni F, Cavagna L.   +7 more
europepmc   +1 more source

Rapid and Integrated Bacterial Evolution Analysis unveils gene mutations and clinical risk of Klebsiella pneumoniae [PDF]

Kojiro Uemura, Toyotaka Sato, Soh Yamamoto, Noriko Ogasawara, Jirachaya Toyting, Kotaro Aoki, Akira Takasawa, Masayuki Koyama, Atsushi Saito, Takayuki Wada, K. Okada, Yurie Yoshida, Koji Kuronuma, Chie Nakajima, Yasuhiko Suzuki, Motohiro Horiuchi, Kenichi Takano, Satoshi Takahashi, Hirofumi Chiba, Shin‐ichi Yokota   +19 more
openalex   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source